Substrate
health

Supreme Court Considers Cancer Warning Requirement for Monsanto's Roundup

The U.S. Supreme Court heard arguments on whether Monsanto must add a cancer warning to its Roundup weedkiller, following a $1.25 million verdict awarded to plaintiff John Durnell. The case examines if federal EPA regulations preempt state court lawsuits over labeling. The Trump administration supports Monsanto's owner, Bayer, in challenging the verdict.

Usa Today
1 source·Apr 29, 9:29 AM(6 days ago)·2m read
|
Supreme Court Considers Cancer Warning Requirement for Monsanto's RoundupUsa Today
Audio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.

The U.S. Supreme Court heard oral arguments on April 27, 2026, in a case challenging whether Monsanto's Roundup weedkiller requires a cancer warning label. The case stems from a $1.25 million jury verdict awarded to John Durnell, who developed non-Hodgkin's lymphoma after using the product for over two decades.

Durnell, a resident of a historic neighborhood in St. Louis, used Roundup to control weeds in parks and playgrounds as part of his neighborhood association duties. He attributes his blood cancer to glyphosate, the key ingredient in Roundup. His lawsuit claims Monsanto failed to warn users of potential cancer risks.

The central issue is whether EPA approval of Roundup's label, which does not include a cancer warning, preempts state court claims for failure to warn. Durnell's attorney argued that federal law and EPA regulations do not prohibit Monsanto from adding such a warning.

Monsanto's attorneys stated that the EPA did not require a cancer warning and that the company could not unilaterally change the label without violating federal rules. Justice Brett Kavanaugh highlighted the federal law's purpose of ensuring uniformity in pesticide labeling across states.

He expressed concern that allowing state lawsuits could undermine this uniformity. Chief Justice John Roberts suggested that state lawsuits might address gaps in EPA reviews, which can occur years apart, by responding faster to new information about product risks.

The Trump administration supports Bayer in this case, arguing that federal regulations should prevail. This stance differs from the position taken by the Justice Department during the Biden administration, which allowed such lawsuits to proceed. President Trump has also promoted domestic production of glyphosate and supported congressional efforts for liability protections.

Glyphosate, introduced in the 1970s, is used in farming with genetically modified seeds resistant to it, as well as by home gardeners. The EPA regulates pesticides but has not mandated a cancer warning for Roundup. The justices did not clearly indicate a leaning during arguments, and a decision is pending.

USA TODAY Supreme Court Correspondent Maureen Groppe reported that the outcome remains uncertain, as it was difficult to discern a majority view among the nine justices.

Key Facts

John Durnell
awarded $1.25 million verdict against Monsanto
Glyphosate
key ingredient in Roundup, linked by plaintiff to cancer
EPA Role
regulates pesticides without requiring cancer warning
Trump Administration
supports Bayer in opposing state lawsuits
Supreme Court Arguments
focused on federal preemption of state claims

Story Timeline

3 events
  1. 2026-04-27

    The Supreme Court heard oral arguments in the case challenging Monsanto's Roundup labeling.

    1 sourceUsa Today
  2. Prior to 2026

    John Durnell used Roundup for over two decades and developed non-Hodgkin's lymphoma.

    1 sourceUsa Today
  3. 1970s

    Glyphosate was introduced and became integral to U.S. farming.

    1 sourceUsa Today

Potential Impact

  1. 01

    A ruling favoring Monsanto could limit future state lawsuits against pesticide makers.

  2. 02

    If the verdict is upheld, Bayer may face additional litigation over Roundup labeling.

  3. 03

    The decision could influence EPA's approach to pesticide warning requirements.

  4. 04

    Congressional efforts for glyphosate liability protections may gain momentum.

Transparency Panel

Sources cross-referenced1
Framing risk18/100 (low)
Confidence score65%
Synthesized bySubstrate AI
Word count362 words
PublishedApr 29, 2026, 9:29 AM
Bias signals removed2 across 2 outlets
Signal Breakdown
Loaded 1Amplifying 1

Related Stories

Trump Nominates Dr. Nicole Saphier for Surgeon General After Previous Nominee WithdrawsThe Times
health3 days agoUpdated

Trump Nominates Dr. Nicole Saphier for Surgeon General After Previous Nominee Withdraws

President Trump announced Dr. Nicole Saphier, a 44-year-old radiologist and Fox News contributor, as his nominee for U.S. surgeon general on Thursday, following the withdrawal of Dr. Casey Means due to insufficient Senate support. Saphier, who authored a book titled Make America…

The Times
Stat
The Atlantic
Npr
Washington Examiner
5 sources
Nancy Cox, Former CDC Influenza Division Leader, Dies at 77 from GlioblastomaStat
health10 days agoDeveloping

Nancy Cox, Former CDC Influenza Division Leader, Dies at 77 from Glioblastoma

Nancy Cox, who led the CDC's influenza team for 22 years and contributed to global flu surveillance, died Thursday from glioblastoma. She was 77. Colleagues praised her role in pandemic preparedness and vaccine development.

Stat
1 source
Senate Report Finds Most Drugmakers Raised Prices Despite Trump-Era DealsSubstrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)
health19 days ago

Senate Report Finds Most Drugmakers Raised Prices Despite Trump-Era Deals

A recent Senate report indicates that 15 of 16 drugmakers involved in a Trump administration initiative have increased prescription drug prices since early 2025. The report also questions the effectiveness of the TrumpRx online platform in providing savings to patients.

The Independent
1 source